Shareholders to Vote on Highly Dilutive Equity Plan and Quorum-Assisting Preferred Stock Amidst Going Concern
COSM is trading near its 52-week low of $0.246 (5.9% above the low) on elevated volume (2.4× avg).
Summary
Cosmos Health Inc. is seeking shareholder approval for a new equity plan with substantial dilution potential and a unique preferred stock class to ensure meeting quorums, against a backdrop of financial distress and a significant disconnect between executive pay and company performance.
Key Events · Corporate Governance and Compliance · COSM
-
Highly Dilutive Equity Incentive Plan Proposed
Shareholders will vote on a new 2026 Omnibus Equity Incentive Plan reserving 10,000,000 shares for awards, representing a potential 16.68% dilution based on current outstanding shares. This follows previous large equity grants and comes amidst the company's 'going concern' warning.
-
Quorum-Assisting Preferred Stock Introduced
A proposal seeks approval for Series B Preferred Stock with 100,000,000 votes, exclusively for establishing a quorum at shareholder meetings. This mechanism aims to mitigate operational risk from low retail investor engagement but does not grant voting power on substantive matters.
-
Significant Executive Compensation Disconnect
The filing reveals a substantial gap between executive compensation and company performance. CEO Grigorios Siokas received $3.55 million in total compensation in 2025, while the company reported a net loss of $19.1 million and negative total shareholder return.
-
Compliance Failures Noted
Several insiders, including the CEO and CFO, failed to timely file Section 16(a) reports for incentive shares granted in December 2025, indicating internal control weaknesses.
Analysis · COSM · Trade & Services
Shareholders are asked to approve a new equity incentive plan that could add 10 million shares, representing a potential 16.68% dilution to existing shareholders. This comes as the company faces a 'going concern' warning and has recently filed for significant share resale. Additionally, a proposal for Series B Preferred Stock, granting 100 million votes solely for quorum purposes, highlights challenges in shareholder engagement and governance. The filing also reveals a significant disconnect between executive compensation and the company's negative financial performance, with the CEO receiving $3.55 million in 2025 while the company reported a $19.1 million net loss and negative shareholder returns. Multiple insiders also failed to timely file Section 16(a) reports, indicating compliance weaknesses.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.8% of the 1864 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COSM was trading at $0.26 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $15.6M. The 52-week trading range was $0.25 to $1.32. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.